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Abstract
Background: Iceland's geographical isolation with a stable and small population gives a rare
opportunity for follow-up studies of medical interventions. Total hip replacements (THR) have
been done at FSA Central Hospital in Akureyri, Iceland since 1982 with the Exeter hip implant being
in use from the beginning.
Methods: Hospital records for all patients operated on with THR between 1982 and the end of
1999 were reviewed and the patients were followed until the end of 2001. Information was
gathered regarding the indication for primary surgery, the reason for revision if needed, as well as
that of any complications. Survival statistics were used to calculate the cumulative revision rate.
Results: The mean age at primary THR was 68.4 years for males and 68.8 years for females. 654
primary THRs were done; of which 571 (87 %) were due to osteoarthritis. 37 of the primary
arthroplasties had been revised before the end of year 2001.
Conclusion: We have in this unique 2–20 year study of 654 THRs with no loss to follow-up for
the patients, found revision rates that conform with the large Swedish THR registry. Complication
rates in general are in agreement with that reported for other comparable patient groups, while
infection rates appear lower.
Background
Total hip replacements (THR) were introduced in Iceland
in 1967 and operations begun at FSA Central Hospital
Akureyri in 1982 when the orthopedic department
opened. The cemented Exeter prosthesis was used from
the beginning. FSA Central Hospital is the second largest
hospital in Iceland, and although it primarily serves a lo-
cal population of forty thousand, patients from the whole
of Iceland are able to seek service there. About 15 % of the
THRs operated at FSA hospital come from outside the
Akureyri service area.
In Iceland, as in other Scandinavian countries, all persons
have a unique personal identification number. This, com-
bined with a highly computerized national health system,
makes it possible to identify all patients operated on for a
given diagnosis or by a certain procedure in Iceland [1].
The National Census and death register makes it possible
to locate all Icelanders, that is where they live and if they
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are alive. With a total Icelandic population of only 280
000 and a close contact between colleagues it is possible
to follow all those who have undergone a THR in Iceland.
The primary purpose of this study was to compare the re-
vision rate of Exeter THR's inserted at the FSA with that of
other hospitals found in the literature, and furthermore to
assess the complication rate by the use of a detailed com-
plication register in a study cohort without loss to follow-
up for the patients.
Methods
Through a computer-aided search of hospital records, we
obtained information on all patients who had undergone
THR at Akureyri hospital between the years 1982 and
2000. All medical records were checked to confirm the di-
agnosis, search for complications and gather the reasons
for any revisions performed. Since 1992 this information
has been registered prospectively. The personal identifica-
tion number was used to check if a patient had sought
service in other orthopedic departments in Iceland or
moved abroad, which none had, after the primary proce-
dure had been performed. Surgical technique and prophy-
lactic measures against thrombosis and infection at
Akureyri Hospital have been quite constant throughout
the eighteen-year period studied here. Prophylactic antibi-
otics and compression stockings were thus used in all cas-
es. Low molecular weight heparin replaced dextran as
anti-thrombotic treatment in 1992. The same five experi-
enced surgeons did 99 % of the operations. All patients
were operated on with a posterolateral incision and a pos-
terior arthrotomy, without the use of trochanteric osteot-
omy. The same type of cement (Palacos® with gentamicin)
was used during the whole period. Vacuum mixing was in-
troduced in 1987. All operations were done in an operat-
ing theatre that is solely for clean orthopedic operations,
but without laminar flow or space suits. 95% of the pa-
tients were operated in spinal and/or epidural anaesthe-
sia. In the beginning a matte stem was in use, which was
replaced by the polished stem during 1987–1989. All poly
cup was used, except for the years 1986–1990, when a
metal backed cup was used. Revision was defined as ex-
change of one or both prosthetic components or removal
of the implant. Complications encountered during the
primary hospital stay were registered at discharge. If a pa-
tient was re-admitted to the hospital due to a complica-
tion, this was registered separately. Bacterial cultures were
taken from wounds with clinically suspected infection
and those with positive culture of pathogenic bacteria and
requiring antibiotic treatment were registered as wound
infection. The diagnosis of pulmonary embolism was
made by clinical symptoms and standard chest x-rays. No
patients were excluded from the study and all patients
were followed until 31st of December 2001, when the
study ended.
Statistics
The cumulative revision rate (CRR) was calculated with
Kaplan-Meier statistics (SPSS-software ver. 11). SPSS ta-
bles were exported to Excel in which graphs were plotted
with the corrected confidence intervals, calculated by the
Wilson quadratic equation with Greenwood and Peto ef-
fective sample size estimates[2] (the scripts used were
those used by the Swedish Knee Register).
Curves were cut-off when 40 hips remained at risk. Cox's
regression was used to compare time periods adjusting for
gender and age.
Results
Survival
Between November 1982 and January 2000 654 primary
hip replacements in 548 patients were done using the Ex-
eter prosthesis. The preoperative diagnosis in primary
THR was osteoarthritis (571 hips, 87 %), rheumatoid ar-
thritis and other forms of arthritis (17 hips, 3 %), hip frac-
tures and complications of hip fractures (42 hips, 6 %)
and other reasons (24 hips, 4 %). The mean age for men
undergoing primary THR for osteoarthritis was 68.4 years
and for females 68.8 years. The average hospital stay de-
creased from 22 days in the beginning of the study to 11
days in 1999. At the end of the study 158 of the 591 pa-
tients had died.
At the end of the follow-up period 37 of the 654 primary
arthroplasties had undergone revision. This included
three implants primarily inserted at FSA Hospital but re-
vised at other hospitals. The reasons for revisions were
aseptic loosening (28 cases, 4.3 %, including 2 stem frac-
tures (older matte stem) at 7 years and 10 years postoper-
atively), recurrent dislocations (7 cases, 1.1 %) and
infection (2 cases, 0.3 %) (Table 1). One female patient
had revisions on both hips due to recurrent dislocations
and one male had both hips revised because of aseptic
loosening.
Survival statistics for primary THR for OA using aseptic
loosening as an endpoint show that for the whole period
the revision rate after 10 years is 6 % and after 16 years 10
% (Fig. 1). For primary OA using all revisions as an end-
point the respective numbers are 8% at 10 years and 13%
at 16 years (Fig. 2). After 1990 only the polished Exeter
stem and all-poly cup was used and after 1990 modern ce-
menting techniques were implemented. The 10 year sur-
vival for primary OA hips were 4% using aseptic loosening
as an endpoint and 7% using all revisions as an endpoint.
Cox regression comparing the 2 time periods (1982–1990
and 1991–2000) adjusting for gender and age showed no
significant difference in risk of revision. The gender did
not significantly affect the risk while the risk decreased
with increasing age.BMC Musculoskeletal Disorders 2003, 4 http://www.biomedcentral.com/1471-2474/4/6
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Complications
All complications that occurred during the hospital stay
were registered (Table 2). There were 10 cases of pulmo-
nary embolism, out of which two occurred after discharge.
All were non-fatal. It is worth mentioning that after the in-
troduction of low molecular heparin prophylaxis in 1992
only two cases of deep venous thrombosis (DVT) or pul-
monary embolism have been diagnosed. In the 7 cases of
nerve injury the recovery varied from partial to complete.
The 20 cardiac and cerebrovascular incidents included
atrial fibrillation, myocardial infarction, heart failure and
cerebrovascular infarction, none of which were fatal. Two
wound infections were caused by S. aureus and after treat-
ment with antibiotics the patients had no sequelae. Only
4 cases of urinary tract infection were diagnosed, this may
be due to the prophylactic use of ampicillin for all patients
Figure 1
Cumulative revision rate for the period between 1982 and 2000. Cumulative revision rate due to aseptic loosening of 
primary THR due to OA for the period between 1982 and 2000. The shadowed area indicates the 95 % confidence interval. 
Curves were cut off when 40 patients remained for analysis.
Table 1: Reasons for revision of primary arthroplasties
Cases M/F ratio (Cases) Total revision Cup revision Femur revision
All reasons 37 12/25 13 17 7
Aseptic loosening 26 8/18 10 13 3
Stem fracture 2 1/1 1 0 1
R e c u r r e n t  d i s l o c a t i o n s 71 / 6 043
Infection 2 2/0 2 0 0
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who got a urinary catheter. One patient died from compli-
cations of diverticulitis of the colon with septicaemia,
which resulted in a wound infection with mixed culture.
The cause of death was intraabdominal infection. Com-
plications listed as other were mainly adverse drug reac-
tions and gastrointestinal problems.
Figure 2
Cumulative revision rate for the period between 1982 and 2000. Cumulative revision rate due to any cause of primary 
THR due to OA for operations done between 1982 and 2000. The shadowed area indicates the 95 % confidence interval. 
Curves were cut off when 40 patients remained for analysis.
Table 2: Complications of primary THR encountered until hospital discharge or requiring re-admission.
Cases %
DVT and/or PE* 10 1.5%
Wound infection 3 0.5%
Wound rupture 2 0.3%
Nerve injury 7 1.1%
Dislocations 33 5.0%
Intraoperative fracture 1 0.2%
Cardiac or cerebrovascular incident 20 3.1%
Urinary tract infections 4 0.6%
Death 1 0.2%
Other 24 3.7%
Total 109 16.6%
* DVT = deep venous thrombosis, PE = pulmonary embolism.
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Discussion
The Exeter hip prosthesis was developed and introduced
in Exeter, England in 1970 and was intended for use
through the posterior approach, allowing accurate inser-
tion and requiring minimal operative assistance. In 1976
the surface finish of the stem was changed from polished
to matte, which was followed by an increase in aseptic
loosening. The polished stem was thus re-introduced in
1986, which resulted in a decrease in stem loosening [3].
Metal backing of the cup was introduced in 1986, largely
based on theoretical grounds and again led to an increase
in aseptic loosening of the cup [4]. An all-plastic cup re-
placed it in 1990 [5].
The demographics of the study group are similar to re-
ports from other Scandinavian countries, although prima-
ry osteoarthritis was a more common reason for THR (87
% vs. 70–80 % in the other Scandinavian countries [3,6–
8]. This is consistent with osteoarthritis being more com-
mon in Iceland than in e.g. Sweden [9].
Conclusions
We present the results of 654 primary THR's performed
from 1982 until 2000. Our results are comparable with
those presented in other Scandinavian hip registers. We
also present what we believe to be a complete register of
all complications incurred during or after the operations.
Perhaps the most unique aspect and major strength of this
study is that no patient was lost to follow-up or excluded
from analysis. It is commonly assumed in survival analy-
sis and complication reports that patients lost to follow-
up would have had the same outcome as those not lost to
follow-up. However, recent studies have shown that those
lost to follow-up have poorer results than the rest, under-
lining the importance of low rate of loss to follow-up [10].
The incidence of nerve injury, dislocation and pulmonary
embolism was comparable to recently published results
[11], while the incidence of wound infection was lower
[12]. Both matte and polished femoral components were
used and acetabular cups were pure polyethylene or with
metal backing. Similar to the Swedish THR registry we
note an improvement in the results during the last decade
with the implementation of modern cementing tech-
niques and better implants.
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